Equity Profile

MCK

McKesson Corporation

Health CareHealth Care Distributors$93.2B

Aug5Wed

Pre-Earnings Brief

UpcomingQ1-2027After Close5:00 PM EDT

Company Snapshot

McKesson Corporation is a leading health care distributor that plays a vital role in the supply chain by delivering pharmaceuticals and medical supplies to hospitals and pharmacies. With a market cap of $91 billion, the company is crucial in ensuring that health care providers have the necessary products to serve patients effectively.

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of profitability and is closely watched by investors to gauge the company's financial health.

Not available

Revenue Growth

Revenue growth reflects the company's ability to increase sales and expand its market presence, which is essential for long-term success.

Not available

Wall Street expectations, options signals, track record, and call prep available with Pro.

MCK Q1-2027 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

75%

Avg EPS Surprise

+3.26%

Avg Stock Reaction

-0.15%

Last Quarter Recap

In the last quarter, McKesson reported an EPS of $11.69, beating estimates by 1.14%. The stock reacted positively, gaining 1.49% the following day.

Management Promises & Guidance

Continued focus on improving supply chain efficiencies.
Commitment to expanding partnerships with health care providers.
Investments in technology to enhance distribution capabilities.

Expectations

Wall Street Expectations

Overall expectations for McKesson's upcoming earnings are mixed, with no analyst estimates available. Investors are keenly awaiting any updates on revenue and profitability.

Bull Case

If McKesson can deliver strong EPS and revenue growth, it may signal robust demand for its services, leading to a positive stock reaction.

Bear Case

Conversely, any signs of declining margins or revenue could raise concerns about the company's competitive position, resulting in a negative market reaction.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will the EPS be for Q1-2027?

The EPS figure will be crucial in determining the company's profitability and whether it can maintain investor confidence.

How is revenue growth trending compared to previous quarters?

Understanding revenue growth will provide insights into the company's market demand and operational efficiency.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating McKesson's ability to leverage its supply chain efficiencies to drive revenue growth despite industry challenges.

Supporting Evidence

The company's recent investments in technology could lead to improved margins.

Past performance shows a strong EPS beat rate of 75%, suggesting potential for positive surprises.

Options pricing indicates a higher expected move than historical averages, hinting at potential volatility.

Key Risk

If revenue growth exceeds expectations, it could significantly shift market sentiment in favor of McKesson.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance will be closely watched as it could set the tone for McKesson's growth trajectory amid a competitive health care landscape.

Bull Confirmed If

An EPS of $12.00 or higher would confirm the bull case, indicating strong profitability.

Bear Confirmed If

An EPS below $10.00 would confirm the bear case, raising concerns about the company's financial health.

Pre-Earnings Positioning

Options Market

Implied Move

±6.54%

Historical Avg

±2.0%

Pricing rich

The options market is pricing in a significant move around the earnings announcement, suggesting that investors expect volatility.

Options are pricing ±5.6% while MCK has averaged ±2.0% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.3%

30d HV

28.8%

Calls (18K)P/C Ratio: 0.66Puts (20K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If McKesson beats expectations, history suggests the stock could rise by an average of 2.7%, confirming strong demand and operational success.

In-Line / Cautious

If results are in line with expectations but cautious commentary is provided, the stock may experience a muted reaction as investors reassess future growth.

Miss

If McKesson misses expectations, the stock could drop by an average of 0.11%, reflecting investor disappointment and concerns over future performance.

Preparation

Congressional Activity

House & Senate STOCK Act disclosures over the trailing 6 months.

Trades

2 buys·1 sell

Members

House + Senate

Est. Notional

$31,003.00–$115,000.00

disclosed dollar ranges

Most Active Members

R-OKMarkwayne MullinSen.
2

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Updates on supply chain efficiencies and their impact on margins.
2Any commentary on partnerships with health care providers.
3Insights into technology investments and their expected returns.
4Trends in demand for pharmaceuticals and medical supplies.
5Management's outlook for the remainder of the fiscal year.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Aug3

ONBMO

ON Semiconductor Corporation

PreviewView

Aug3

LBMO

Company Snapshot

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of profitability and is closely watched by investors to gauge the company's financial health.

Not available

Revenue Growth

Revenue growth reflects the company's ability to increase sales and expand its market presence, which is essential for long-term success.

Not available

Wall Street expectations, options signals, track record, and call prep available with Pro.

MCK Q1-2027 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

75%

Avg EPS Surprise

+3.26%

Avg Stock Reaction

-0.15%

Last Quarter Recap

In the last quarter, McKesson reported an EPS of $11.69, beating estimates by 1.14%. The stock reacted positively, gaining 1.49% the following day.

Management Promises & Guidance

Continued focus on improving supply chain efficiencies.
Commitment to expanding partnerships with health care providers.
Investments in technology to enhance distribution capabilities.

Expectations

Wall Street Expectations

Overall expectations for McKesson's upcoming earnings are mixed, with no analyst estimates available. Investors are keenly awaiting any updates on revenue and profitability.

Bull Case

If McKesson can deliver strong EPS and revenue growth, it may signal robust demand for its services, leading to a positive stock reaction.

Bear Case

Conversely, any signs of declining margins or revenue could raise concerns about the company's competitive position, resulting in a negative market reaction.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will the EPS be for Q1-2027?

The EPS figure will be crucial in determining the company's profitability and whether it can maintain investor confidence.

How is revenue growth trending compared to previous quarters?

Understanding revenue growth will provide insights into the company's market demand and operational efficiency.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating McKesson's ability to leverage its supply chain efficiencies to drive revenue growth despite industry challenges.

Supporting Evidence

The company's recent investments in technology could lead to improved margins.

Past performance shows a strong EPS beat rate of 75%, suggesting potential for positive surprises.

Options pricing indicates a higher expected move than historical averages, hinting at potential volatility.

Key Risk

If revenue growth exceeds expectations, it could significantly shift market sentiment in favor of McKesson.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance will be closely watched as it could set the tone for McKesson's growth trajectory amid a competitive health care landscape.

Bull Confirmed If

An EPS of $12.00 or higher would confirm the bull case, indicating strong profitability.

Bear Confirmed If

An EPS below $10.00 would confirm the bear case, raising concerns about the company's financial health.

Pre-Earnings Positioning

Options Market

Implied Move

±6.54%

Historical Avg

±2.0%

Pricing rich

The options market is pricing in a significant move around the earnings announcement, suggesting that investors expect volatility.

Options are pricing ±5.6% while MCK has averaged ±2.0% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.3%

30d HV

28.8%

Calls (18K)P/C Ratio: 0.66Puts (20K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If McKesson beats expectations, history suggests the stock could rise by an average of 2.7%, confirming strong demand and operational success.

In-Line / Cautious

If results are in line with expectations but cautious commentary is provided, the stock may experience a muted reaction as investors reassess future growth.

Miss

If McKesson misses expectations, the stock could drop by an average of 0.11%, reflecting investor disappointment and concerns over future performance.

Preparation

Congressional Activity

House & Senate STOCK Act disclosures over the trailing 6 months.

Trades

2 buys·1 sell

Members

House + Senate

Est. Notional

$31,003.00–$115,000.00

disclosed dollar ranges

Most Active Members

R-OKMarkwayne MullinSen.
2

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Updates on supply chain efficiencies and their impact on margins.
2Any commentary on partnerships with health care providers.
3Insights into technology investments and their expected returns.
4Trends in demand for pharmaceuticals and medical supplies.
5Management's outlook for the remainder of the fiscal year.